S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
S&P 500   4,471.37
DOW   35,294.76
QQQ   368.94
pixel
pixel
pixel
NASDAQ:ITCI

Intra-Cellular Therapies SEC Filings & 10K Form

$39.30
-0.08 (-0.20 %)
(As of 10/15/2021 04:00 PM ET)
Add
Compare
Today's Range
$39.20
$40.00
50-Day Range
$28.72
$39.46
52-Week Range
$22.92
$44.80
Volume468,771 shs
Average Volume517,742 shs
Market Capitalization$3.20 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.29

Intra-Cellular Therapies (NASDAQ:ITCI) SEC Filings

DateFilerForm TypeView
08/09/2021
6:37 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2021
6:31 AM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/22/2021
3:34 PM
Intra-Cellular Therapies (Issuer)
Rawlins Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
3:30 PM
Intra-Cellular Therapies (Issuer)
Rawlins Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/22/2021
3:26 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
3:23 PM
Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/22/2021
3:21 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2021
4:02 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2021
3:05 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2021
3:02 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2021
5:00 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2021
5:02 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2021
6:37 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2021
6:31 AM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2021
6:42 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2021
6:07 AM
Intra-Cellular Therapies (Filer)
Form DEFA14A
04/19/2021
4:28 PM
Intra-Cellular Therapies (Filer)
Form PRE 14A
04/02/2021
4:31 PM
Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
4:29 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
4:27 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2021
4:26 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2021
4:43 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
3:28 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
3:24 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
3:20 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
3:12 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2021
6:54 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2021
6:46 AM
Intra-Cellular Therapies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/22/2021
7:09 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
7:07 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
7:05 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
7:03 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
7:01 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
7:09 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2021
4:18 PM
BB BIOTECH AG (Filed by)
Intra-Cellular Therapies (Subject)
Form SC 13G/A
02/10/2021
10:03 AM
Intra-Cellular Therapies (Subject)
Form SC 13G/A
02/09/2021
2:23 PM
Intra-Cellular Therapies (Subject)
WASATCH ADVISORS INC (Filed by)
Form SC 13G
02/08/2021
9:25 AM
FMR LLC (Filed by)
Intra-Cellular Therapies (Subject)
Form SC 13G/A
01/29/2021
8:57 AM
BlackRock Inc. (Filed by)
Intra-Cellular Therapies (Subject)
Form SC 13G/A
01/12/2021
6:07 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2021
6:06 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2021
6:05 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2021
6:03 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/12/2021
6:01 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:13 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:11 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:09 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:07 PM
Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:05 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:03 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/05/2021
5:01 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/21/2020
3:03 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2020
3:07 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/19/2020
7:05 PM
Halstead Michael (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2020
4:51 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2020
4:51 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2020
6:45 AM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2020
6:40 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2020
5:00 PM
Intra-Cellular Therapies (Issuer)
Mates Sharon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2020
3:02 PM
Durgam Suresh K. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/16/2020
3:04 PM
Intra-Cellular Therapies (Issuer)
Neumann Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2020
3:17 PM
Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2020
3:13 PM
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2020
3:38 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2020
4:03 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2020
6:08 PM
Hineline Lawrence J. (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2020
3:47 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2020
3:44 PM
Intra-Cellular Therapies (Filer)
Form 424B5
09/11/2020
3:15 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2020
3:02 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2020
4:26 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2020
3:40 PM
Intra-Cellular Therapies (Filer)
Form 424B5
09/09/2020
6:13 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
3:16 PM
Intra-Cellular Therapies (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/10/2020
7:17 AM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/10/2020
6:52 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2020
4:48 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
6:12 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
6:05 PM
Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
6:02 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2020
5:58 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2020
8:14 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2020
8:17 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
8:07 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
6:17 PM
Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
6:13 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
6:09 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
6:06 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
6:03 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
3:16 PM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2020
4:37 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2020
6:48 PM
Intra-Cellular Therapies (Issuer)
MARCUS JOEL S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2020
4:20 PM
Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2020
3:31 PM
Intra-Cellular Therapies (Filer)
Form DEFA14A
05/07/2020
6:42 AM
Intra-Cellular Therapies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2020
6:32 AM
Intra-Cellular Therapies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/02/2020
5:05 PM
Alafi Christopher D (Reporting)
Intra-Cellular Therapies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
5:01 PM
Intra-Cellular Therapies (Issuer)
LERNER RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
4:55 PM
Intra-Cellular Therapies (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2020
4:50 PM
Intra-Cellular Therapies (Issuer)
RIGGS RORY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 10/16/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.